Suppr超能文献

自发性冠状动脉夹层的最佳治疗或血运重建方法:系统评价和荟萃分析。

Medical treatment or revascularisation as the best approach for spontaneous coronary artery dissection: A systematic review and meta-analysis.

机构信息

1 Department of Cardiology, Baixo Vouga Hospital Centre, Portugal.

2 CIDMA/IBIMED/Department of Mathematics, University of Aveiro, Portugal.

出版信息

Eur Heart J Acute Cardiovasc Care. 2018 Oct;7(7):614-623. doi: 10.1177/2048872617706502. Epub 2017 Apr 28.

Abstract

INTRODUCTION

Patients presenting with spontaneous coronary artery dissection (SCAD) may receive either conservative medical management or a revascularisation strategy. There is still a lack of consensus with respect to the best treatment approach for SCAD.

OBJECTIVES

We sought to determine whether outcomes differ between the first-line treatment approaches (conservative versus revascularisation) in patients with SCAD.

METHODS

We searched Medline, EMBASE and the Cochrane Library for studies published from January 1990 to November 2016 that compared first-line treatments for patients with SCAD. We conducted a pooled risk ratio meta-analysis for four main outcomes: mortality, myocardial infarction (MI), SCAD recurrence and target vessel revascularisation (TVR).

RESULTS

We identified 11 non-randomised studies that included a total of 631 patients. A pooled meta-analysis showed no significant difference between conservative management and revascularisation approaches in mortality (risk difference [RD] = 0.01; 95% confidence interval [CI] = -0.01 to 0.04; I = 0%; p = 1), MI (RD = -0.01; 95% CI = -0.04 to 0.03; I = 0%; p = 0.5) or SCAD recurrence (RD = -0.01; 95% CI = -0.06 to 0.05; I = 0%; p = 0.74). Revascularisation as an initial first-line approach was associated with an estimated additional risk of TVR of 6.3% (RD = 0.06; 95% CI = 0.01-0.11; I = 0%; p = 0.96).

CONCLUSION

The results demonstrate an increased risk of TVR when revascularisation was used as the initial first-line treatment approach. The treatment decision must be individualised and be based on both clinical and angiographic factors, but conservative therapy should prevail in most cases.

摘要

介绍

自发性冠状动脉夹层(SCAD)患者可接受保守的药物治疗或血运重建策略。目前对于 SCAD 的最佳治疗方法仍缺乏共识。

目的

我们旨在确定 SCAD 患者的一线治疗方法(保守与血运重建)之间的结局是否存在差异。

方法

我们检索了从 1990 年 1 月至 2016 年 11 月发表的比较 SCAD 患者一线治疗的 Medline、EMBASE 和 Cochrane 图书馆研究。我们对四项主要结局(死亡率、心肌梗死、SCAD 复发和靶血管血运重建)进行了汇总风险比荟萃分析。

结果

我们确定了 11 项非随机研究,共纳入 631 例患者。汇总荟萃分析显示,在死亡率(风险差异 [RD] = 0.01;95%置信区间 [CI] = -0.01 至 0.04;I = 0%;p = 1)、心肌梗死(RD = -0.01;95%CI = -0.04 至 0.03;I = 0%;p = 0.5)或 SCAD 复发(RD = -0.01;95%CI = -0.06 至 0.05;I = 0%;p = 0.74)方面,保守治疗与血运重建策略之间无显著差异。作为初始一线治疗方法,血运重建与 TVR 的估计额外风险相关,风险比为 6.3%(RD = 0.06;95%CI = 0.01 至 0.11;I = 0%;p = 0.96)。

结论

结果表明,当血运重建作为初始一线治疗方法时,TVR 的风险增加。治疗决策必须个体化,并基于临床和血管造影因素,但在大多数情况下应优先采用保守治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验